Generation of dendritic cell-based vaccines for cancer therapy
- PMID: 12085199
- PMCID: PMC2746586
- DOI: 10.1038/sj.bjc.6600316
Generation of dendritic cell-based vaccines for cancer therapy
Abstract
Dendritic cells play a major role in the generation of immunity against tumour cells. They can be grown under various culture conditions, which influence the phenotypical and functional properties of dendritic cells and thereby the consecutive immune response mainly executed by T cells. Here we discuss various conditions, which are important during generation and administration of dendritic cells to elicit a tumouricidal T cell-based immune response.
Copyright 2002 Cancer Research UK
Figures
References
-
- BanchereauJSteinmanRM1998Dendritic cells and the control of immunity Nature 392245252 - PubMed
-
- BennettSRCarboneFRKaramalisFFlavellRAMillerJFHeathWR1998Help for cytotoxic-T-cell responses is mediated by CD40 signalling Nature 393478480 - PubMed
-
- BregniMShammahSMalaffoFDi NicolaMMilanesiMMagniMMatteucciPRavagnaniFJordanCTSienaSGianniAM1998Adenovirus vectors for gene transduction into mobilized blood CD34+ cells Gene Ther 5465472 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
